Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT00717236 ×

NCT00717236

This funder is selected. Its supporting articles are shown below.

NCT007172361

Articles mentioning NCT00717236

1 articles · page 1 of 1

Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial

rmdopen · abstract · 2026-01-30 · 1 matching annotations

80.0%

NCT00717236 Disease Activity Score 28 rheumatoid arthritis certolizumab pegol RA CZP

…d prior inadequate responses to TNFis.Trial registration number NCT00717236.…